Litcius/Paper detail

Histone methyltransferase SETD2 inhibits tumor growth via suppressing CXCL1-mediated activation of cell cycle in lung adenocarcinoma

You Zhou, Xiao Zheng, Bin Xu, Haifeng Deng, Lujun Chen, Jingting Jiang

2020Aging22 citationsDOIOpen Access PDF

Abstract

suppressing CXCL1-mediated activation of cell cycle, indicating that the regulation of H3K36me3 level by targeting SETD2 and/or the administration of downstream CXCL1 might represent a potential therapeutic way for new treatment in LUAD.

Topics & Concepts

CXCL1Histone methyltransferaseCancer researchMethyltransferaseAdenocarcinomaHistoneChemistryCell biologyBiologyInternal medicineMedicineMethylationChemokineReceptorBiochemistryGeneCancerEpigenetics and DNA MethylationRNA modifications and cancerLung Cancer Research Studies
Histone methyltransferase SETD2 inhibits tumor growth via suppressing CXCL1-mediated activation of cell cycle in lung adenocarcinoma | Litcius